Using our mobile app? Be sure to check for any new app updates to receive any enhancements.
Logo

Get Healthy!

Results for search "Cancer: Leukemia".

14 Jan

Cancer Cases On The Rise In Workers Who Responded To The World Trade Center Attack.

And for the first time leukemia incidence increases significantly, researchers say.

Health News Results - 16

Teen and young adult cancer survivors are nearly twice as likely to be hospitalized as those who haven't had cancer, a new study finds.

"Few studies have investigated health risk in adolescents and young adults after cancer treatment," said study author Chelsea Anderson, a postdoctoral fellow at the American Cancer Society.

She and her colleagues from the University of Utah ...

The risks faced by U.S. bone marrow transplant patients have dropped sharply, a new study shows.

While this type of transplant can be lifesaving for patients with blood cancers (such as leukemia) and other diseases, there are potentially life-threatening risks, the researchers noted.

But the new analysis of 1,148 patients who had bone marrow transplants at the Seattle Cancer...

Since the 1970s, serious heart disease among childhood cancer survivors had declined remarkably, a new study finds.

The decline suggests that efforts to make cancer treatments, including radiation, less toxic are paying off, researchers say.

For the study, researchers led by Dr. Daniel Mulrooney, from St. Jude Children's Research Hospital in Memphis, Tenn., collected data ...

Nearly two decades after terrorists attacked New York's World Trade Center, certain cancers are striking police and recovery workers who saved lives, recovered bodies and cleaned up the wreckage.

This particular group of responders appears to have an increased risk of developing thyroid cancer, leukemia and prostate cancer, as well as a slightly elevated overall risk of cancer, resear...

A drug used to fight chronic myeloid leukemia might also relieve symptoms of Parkinson's disease, a new study finds.

In a phase 2 clinical trial, researchers found that the drug nilotinib (brand name: Tasigna) increased production of dopamine and halted decline in motor function. It was well-tolerated by most participants.

"We found that nilotinib is reasonably safe using d...

Boosting exercise capacity may protect the mental functioning of childhood leukemia survivors, according to a new study.

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Due to their disease and treatment, childhood ALL survivors are at increased risk for problems with thinking and memory, as well as reduced exercise capacity, researchers said.

"Our re...

Patients with a form of blood cancer known as multiple myeloma who haven't responded to other therapies might have a new weapon against the disease, researchers say.

A drug called selinexor appeared to help patients with the blood and bone marrow cancer, according to a clinical trial involving 122 people.

"This study proved that a novel, first-in-class drug with a new mechan...

If a close relative has had blood cancer, you're more likely to get it, a large new study reports.

The researchers analyzed data from 16 million people in Sweden, including more than 153,000 diagnosed with blood cancer and more than 391,000 of their first-degree relatives: parents, siblings or children.

Patients with a family link accounted for 4.1% of all blood cancer ...

A two-drug combo helps patients with a common form of leukemia survive longer than the current standard of care, a new clinical trial finds.

The phase 3 trial of more than 500 U.S. patients with chronic lymphocytic leukemia (CLL) found that a combination of rituximab and ibrutinib extended patient survival.

Specifically, 89.4% of the patients who received the experimenta...

More than 8.7 million years of life and about $94 billion in earnings were lost to cancer in the United States in 2015, researchers say.

Cancer is the nation's second-leading killer and is expected to cause nearly 607,000 deaths this year. These premature deaths and the lost productivity they cause impose a significant economic burden, the study authors explained.

In this s...

The chances of finding an unrelated bone marrow donor are higher for U.S. patients of European descent than for those of non-European descent, a new study finds.

A bone marrow transplant can sometimes help people with life-threatening blood cancers by replacing the patient's cells with healthy ones from a donor. A brother or sister with the same genetic markers as the recipient is the...

All expectant parents worry, and for those undergoing fertility treatments, there are additional concerns about the health of their child.

But a new study finds one less thing they need to stress over -- their children don't appear to be at greater risk of cancer than other children.

"These results provide reassuring evidence that children conceived as a result of fertility ...

Poverty is a major reason black and Hispanic children with some types of cancer have lower survival rates than white patients, a new study finds.

Researchers examined U.S. government data on nearly 32,000 black, Hispanic and white children who were diagnosed with cancer between 2000 and 2011. For several cancers, whites were much more likely to survive than blacks and Hispanics.

...

The increased risk of cancer in people with diabetes is higher for women than men, a new study finds.

Previous research identified the link between diabetes and cancer risk, but this study looked at whether that risk differs between men and women.

The takeaway: Among people with diabetes, women have a 6 percent higher risk of cancer than men, the researchers said.

...

Many adult survivors of childhood cancer don't worry about their future health and may skip crucial screenings and lifestyle changes, a new study shows.

"Some of the increased health risks faced by survivors of childhood cancer can be minimized through early detection and intervention, as well as adoption of healthy behaviors," said study co-leader Todd Gibson, from St. Jude Children'...

Generic drugs tend to trigger big drops in the cost of their expensive, brand-name counterparts, but that has not been the case with the cancer drug commonly known as Gleevec (imatinib).

There's been only a small drop in the price of imatinib since a generic version was introduced to compete with Gleevec, a new study finds.

Gleevec is used to treat chronic myeloid leukemia. ...

Show All Health News Results